<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00821262</url>
  </required_header>
  <id_info>
    <org_study_id>GO/URC/ER/mm 412/DG</org_study_id>
    <nct_id>NCT00821262</nct_id>
  </id_info>
  <brief_title>Sevoflurane in Cardiac Surgery</brief_title>
  <acronym>SEVO AIFA</acronym>
  <official_title>Sevoflurane and Cardiac Protection in High Risk Patients Undergoing Cardiac Surgery. A Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Vita-Salute San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università Vita-Salute San Raffaele</source>
  <brief_summary>
    <textblock>
      Patients undergoing high risk cardiac surgery (combined CABG and valvular procedures) will be
      randomized to receive a total intravenous anesthesia or an anesthesia plan with sevoflurane.

      The investigators want to document whether the cardioprotective properties of volatile agents
      could translate in an improved outcome after cardiac surgery in high risk patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background

      It is commonly believed that the choice of the primary anesthetic agent does not result in
      different outcomes after cardiac surgery. Recent evidence however has indicated that volatile
      anesthetics improve post-ischemic recovery. These results have been summarized in a
      meta-analysis of 22 randomized studies, involving 1922 patients: the use of volatile
      anesthetics was associated with significant reductions of myocardial infarctions (24/979
      [2.4%] in the volatile anesthetics group vs 45/874 [5.1%] in the control arm, odds ratio
      [OR]=0.51 [0.32-0.84], and mortality (4/977 [0.4%] vs 14/872 [1.6%], OR=0.31 [0.12-0.80].

      Furthermore, the use of volatile anesthetics was associated with shorter intensive-care unit
      stay (WMD=-7.10 hours [-11.47; -2.73], and time to hospital discharge (WMD=-2.26 days [-3.83;
      -0.68].

      All the studies of the meta-analysis included low risk patients undergoing isolated
      procedures (mostly coronary artery bypass grafting).

      Objectives

      Investigators are planning a large multicentre randomized controlled study to confirm the
      beneficial cardioprotective effects of volatile anesthetics in cardiac surgery as indicated
      by a reduced intensive care stay and/or death in an high risk population of patients
      undergoing combined valvular and coronary procedures. Secondary endpoints will be: cardiac
      troponin release; incidence of myocardial infarction; time on mechanical ventilation;
      postoperative hospital stay

      Methods

      Various centers will randomize 200 patients to receive either a total intravenous anesthesia
      with propofol or an anesthesia with sevoflurane. All patients will receive a standard middle
      dose opiates anesthesia. All the perioperative management will be otherwise identical and
      standardized. Transfer out of the intensive care will be performed with SpO2 94% or greater
      at an FiO2 of 0.5 or less by facemask, adequate cardiac stability with no hemodynamically
      significant arrhythmias, chest tube drainage less than 50 ml/h, urine output greater than 0.5
      ml/kg/h, no intravenous inotropic or vasopressor therapy in excess of dopamine 5 ug/kg/min,
      and no seizure activity.

      Expected Results

      The reduced cardiac damage (reduction in cardiac troponin release and in the incidence of
      myocardial infarction) will translate into a better tissue perfusion and faster recovery as
      documented by reduced intensive care unit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite endpoint or number of dead patients and/or number of patients requiring prolonged intensive care unit stay</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiac troponin release</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of perioperative myocardial infarction</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time on mechanical ventilation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative hospital stay</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Anesthesia</condition>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group will receive Sevoflurane for a 4-6 hours period (from anesthesia induction to transfer to ICU).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive propofol for the same 4-6 hours period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <arm_group_label>sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years

          -  written informed consent

          -  scheduled procedures

        Exclusion Criteria:

          -  ongoing acute myocardial infarction

          -  cardiac troponin &gt;1 ng/ml

          -  previous unusual response to an anesthetic

          -  use of sulfonylurea, theophylline or allopurinol

          -  thoracotomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>giovanni landoni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vita-Salute University of Milano. Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>elena bignami, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vita-Salute University of Milano, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vita-Salute University</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Perugia (H Santa Maria della Misericordia)</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università La Sapienza, Policlinico Umberto I, Roma</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.itacta.org</url>
    <description>ITACTA (Italian Association of Cardiothoracic Anesthesiologists)</description>
  </link>
  <link>
    <url>http://www.metcardio.org/cv/landoni/landoni.html</url>
    <description>Meta-analysis and Evidence-based Medicine Training in Cardiology</description>
  </link>
  <reference>
    <citation>Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, Calabrò MG, Fochi O, Guarracino F, Tritapepe L, De Hert S, Torri G. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2007 Aug;21(4):502-11. Epub 2007 May 7. Review.</citation>
    <PMID>17678775</PMID>
  </reference>
  <reference>
    <citation>Landoni G, Fochi O, Tritapepe L, Guarracino F, Belloni I, Bignami E, Zangrillo A. Cardiac protection by volatile anesthetics. A review. Minerva Anestesiol. 2009 May;75(5):269-73. Epub 2008 Nov 6. Review.</citation>
    <PMID>18987572</PMID>
  </reference>
  <reference>
    <citation>Landoni G, Zangrillo A, Fochi O, Maj G, Scandroglio AM, Morelli A, Tritapepe L, Montorfano M, Colombo A. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth. 2008 Aug;22(4):543-7. doi: 10.1053/j.jvca.2008.02.020. Epub 2008 May 14.</citation>
    <PMID>18662628</PMID>
  </reference>
  <reference>
    <citation>Landoni G, Fochi O, Zangrillo A. Cardioprotection by volatile anesthetics in noncardiac surgery? No, not yet at least. J Am Coll Cardiol. 2008 Apr 1;51(13):1321; author reply 1321-2. doi: 10.1016/j.jacc.2007.12.020.</citation>
    <PMID>18371566</PMID>
  </reference>
  <reference>
    <citation>Landoni G, Calabrò MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E, De Luca M, Tritapepe L, Crescenzi G, Zangrillo A. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth. 2007 Oct;21(5):672-7. Epub 2007 Feb 22.</citation>
    <PMID>17905272</PMID>
  </reference>
  <reference>
    <citation>Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, De Luca M, Fochi O, D'Avolio S, Bignami E, Calabrò MG, Zangrillo A. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol. 2007 Apr;24(4):323-31. Epub 2006 Dec 8.</citation>
    <PMID>17156509</PMID>
  </reference>
  <reference>
    <citation>Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, Scandroglio AM, Maselli D, De Luca M, Marchetti C, Crescenzi G, Zangrillo A. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth. 2006 Aug;20(4):477-83.</citation>
    <PMID>16884976</PMID>
  </reference>
  <reference>
    <citation>Landoni G, Zambon M, Zangrillo A. Reducing perioperative myocardial infarction with anesthetic drugs and techniques. Curr Drug Targets. 2009 Sep;10(9):858-62. Epub 2009 Sep 1. Review.</citation>
    <PMID>19538174</PMID>
  </reference>
  <reference>
    <citation>Bignami E, Biondi-Zoccai G, Landoni G, Fochi O, Testa V, Sheiban I, Giunta F, Zangrillo A. Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth. 2009 Oct;23(5):594-9. doi: 10.1053/j.jvca.2009.01.022. Epub 2009 Mar 19.</citation>
    <PMID>19303327</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2009</study_first_submitted>
  <study_first_submitted_qc>January 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2009</study_first_posted>
  <last_update_submitted>October 13, 2015</last_update_submitted>
  <last_update_submitted_qc>October 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Vita-Salute San Raffaele</investigator_affiliation>
    <investigator_full_name>Giovanni Landoni</investigator_full_name>
    <investigator_title>DM</investigator_title>
  </responsible_party>
  <keyword>Sevoflurane</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Troponin</keyword>
  <keyword>Myocardial Preconditioning</keyword>
  <keyword>Surgery, Cardiac</keyword>
  <keyword>Stents</keyword>
  <keyword>Non-cardiac Surgery</keyword>
  <keyword>Surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

